Leptomeningeal dissemination of anaplastic glioma: prolonged survival in two patients treated with temozolomide

被引：6
|
作者：
Nandipati, Sirisha
Demopoulos, Alexis [1 ,2 ,3 ]
机构：
[1] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY 10029 USA
[2] Mt Sinai Sch Med, Dept Neurosurg, New York, NY 10029 USA
[3] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA
来源：
JOURNAL OF NEURO-ONCOLOGY | 2011年 / 105卷 / 03期
关键词：
GLIOBLASTOMA;
D O I：
10.1007/s11060-011-0611-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：663 / 665
页数：3
相关论文
共 50 条
  • [1] Leptomeningeal dissemination of anaplastic glioma: prolonged survival in two patients treated with temozolomide
    Sirisha Nandipati
    Alexis Demopoulos
    Journal of Neuro-Oncology, 2011, 105 : 663 - 665
  • [2] Prolonged Administration of Temozolomide in Adult Patients with Anaplastic Glioma
    Freyschlag, C. F.
    Smolczyk, D. R.
    Janzen, E.
    Schmieder, K.
    Thome, C.
    Lohr, F.
    Wenz, F.
    Weiss, C.
    Tuettenberg, J.
    Seiz, M.
    ANTICANCER RESEARCH, 2011, 31 (11) : 3873 - 3877
  • [3] Prognostic impact of molecular phenotype in patients with recurrent anaplastic glioma treated with prolonged administration of temozolomide
    Kong, Doo-Sik
    Kim, Hong Rye
    Choi, Yoon-Ra
    Seol, Ho Jun
    Lee, Jung-Il
    Nam, Do-Hyun
    JOURNAL OF CLINICAL NEUROSCIENCE, 2015, 22 (09) : 1425 - 1429
  • [4] PROGNOSTIC VALUE OF MOLECULAR PHENOTYPES IN ANAPLASTIC GLIOMA PATIENTS WITH PROLONGED ADMINISTRATION OF TEMOZOLOMIDE
    Kong, Doo-Sik
    Choi, Yoon-La
    Seol, Ho Jun
    Lee, Jung-Il
    Nam, Do-Hyun
    NEURO-ONCOLOGY, 2013, 15 : 116 - 116
  • [5] SURVIVAL OUTCOMES OF PATIENTS WITH RECURRENT ANAPLASTIC GLIOMA TREATED WITH BEVACIZUMAB
    Hamza, Mohamed
    O'Brien, Barbara
    Mandel, Jacob
    DeGroot, John
    NEURO-ONCOLOGY, 2013, 15 : 110 - 111
  • [6] Lack of Survival Benefit in Patients with Anaplastic Astrocytoma Treated with Temozolomide during Radiotherapy
    Barker, C. A.
    Chang, M.
    Beal, K.
    Chan, T. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S269 - S269
  • [7] Outcomes for Anaplastic Glioma Treated With Radiation Therapy With or Without Concurrent Temozolomide
    McTyre, E.
    Lucas, J. T., Jr.
    Helis, C.
    Farris, M.
    Houseknecht, K.
    Mott, R.
    Laxton, A. W.
    Tatter, S. B.
    Lesser, G. J.
    Chan, M. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E108 - E108
  • [8] Outcomes for Anaplastic Glioma Treated With Radiation Therapy With or Without Concurrent Temozolomide
    McTyre, Emory
    Lucas, John T.
    Helis, Corbin
    Farris, Michael
    Soike, Michael
    Mott, Ryan
    Laxton, Adrian W.
    Tatter, Stephen B.
    Lesser, Glenn J.
    Strowd, Roy E.
    Lo, Hui-Wen
    Debinski, Waldemar
    Chan, Michael D.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (08): : 813 - 819
  • [9] DETECTION OF TEMOZOLOMIDE AND MTIC IN BLOOD OF GLIOMA PATIENTS TREATED WITH TEMOZOLOMIDE
    Anan, Mitsuhiro
    Sadr, Mohamad Seyed
    Alshami, Jad
    Sabau, Carmen
    Sadr, Emad Seyed
    Siu, Vincent
    Guiot, Marie-Christine
    Samani, Amir
    Del Maestro, Rolando
    NEURO-ONCOLOGY, 2010, 12 : 74 - 74
  • [10] Survival of patients with high grade glioma treated with intrathecal thiotriethylenephosphoramide for ependymal or leptomeningeal gliomatosis
    Witham, TF
    Fukui, MB
    Meltzer, CC
    Burns, R
    Kondziolka, D
    Bozik, ME
    CANCER, 1999, 86 (07) : 1347 - 1353
12345